 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| Good Volume on Good News for PSID |
|
 Hot Stock to Watch |
Company: PositiveID Corporation (OTCQB: PSID)
|
Last:
Price: 0.0273
Change (%): + 0.0019 (7.48)
Volume: 4,094,175 |
 |
PositiveID Selected to Present and Exhibit at the 2015 Military Health System Research Symposium August 17-20
DELRAY BEACH, Fla., Aug. 10, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today that it has been selected to present a poster and exhibit at the 2015 Military Health System Research Symposium (MHSRS) Conference on August 17-20, 2015, at the Marriott Harbor Beach Resort in Fort Lauderdale, FL. PositiveID will showcase its biological detection and diagnostics products, primarily its Firefly Dx, during the conference in Booth #50.
The Company’s poster, “Firefly Dx; Point-Of-Care Infectious Disease Detection and Diagnostics,” describes the development of the handheld, point-of-care (POC) diagnostics system for rapid identification of naturally occurring infectious diseases within 20 minutes. The Firefly Dx system uses assay specific, disposable cartridges in conjunction with a handheld device, and is designed to be a cost-effective diagnostic tool capable of easy and rapid onsite analysis against multiple user-defined pathogenic targets of interest.
Firefly Dx is designed to provide real-time, accurate diagnostic results in a handheld device, thereby leading to treatment scenarios at the point of need that are not possible with existing systems, which require lab-based equipment and can take hours or even days to provide results. Firefly’s applications include point-of-need, lab-quality, detection of pathogenic organisms; agricultural and food screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction.
The MHSRS is the Department of Defense’s premier scientific meeting. It is a venue for communicating and discussing new scientific knowledge resulting from military-unique research and development. It is the only military or civilian meeting that focuses specifically on the unique medical needs of the Warfighter.
The MHSRS provides a scholarly forum for the planning and development of future studies aimed at optimizing care for members of the Uniformed Services in operational settings. Held in a collaborative, joint setting, it enables military medical care providers with deployment experience to exchange information with Department of Defense and academic scientists, international partners, and industry on research and related health care initiatives falling under the topic areas of Combat Casualty Care, Military Operational Medicine, Clinical and Rehabilitative Medicine, and Military Infectious Disease. Its goal is to maximize research synergy among all of the branches of military service, while acknowledging the need for service-specific medical capabilities.
The MHSRS is an annual event that is sponsored by the Assistant Secretary of Defense for Health Affairs.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
